EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Selected Elements of the Tumor Microenvironment (MMP-2, MMP-7, TIMP-2, CXCL-9, CXCL-10) in the Serum of Pediatric Patients with Acute Lymphoblastic Leukemia

Aleksandra Kaczorowska, Natalia Miękus-Purwin iD, Anna Owczarzak, Anna Gabrych, Małgorzata Wojciechowska, Ninela Irga-Jaworska, Sylwia Małgorzewicz iD, Małgorzata Rąpała iD, Joanna Stefanowicz iD

Cells · 2025

DOI: 10.3390/cells14040297 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Aleksandra Kaczorowska und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Hematology and Oncology, University Clinical Center of Gdansk, Debinki 7, 80-211 Gdańsk, Poland. Hauptthemen laut MEDLINE: Tissue Inhibitor of Metalloproteinase-2, Matrix Metalloproteinase 2, Tumor Microenvironment, Chemokine CXCL10. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Gdańsk.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, researchers have been paying special attention to the tumor microenvironment (TME). One of the most important factors contributing to the development and progression of cancer is the destruction of elements of the extracellular matrix (ECM). The most important substances involved in regulating the extracellular matrix degradation process are extracellular matrix metalloproteinases (MMPs) and their inhibitors (TIMPs). In the process of cancer cell migration, chemokines secreted by target tissues, as well as the profile of chemokine receptors presented on cancer cells, play a key role. In the presented work, five components of the TME were selected: MMP-2, MMP-7, TIMP-2, CXCL-9, and CXCL-10. In the years 2018–2021, peripheral blood samples were collected before the start of treatment and then on day 33 of intensive treatment from 31 patients diagnosed with ALL. The results indicate that the levels of MMP-2, MMP-7, and TIMP-2 did not statistically significantly change before and during treatment of ALL patients. The decrease in CXCL-9 and CXCL-10 levels in the patients’ serum on the 33rd day of therapy turned out to be statistically significant. Our study indicates that serum is also a valuable material for the evaluation of these substances. Conclusions: CXCL-9 and CXCL-10 could be used as one of markers for monitoring the response to treatment and a potential marker of ALL recurrence in pediatric patients. The role of MMP-2, MMP-7, and TIMP-2 in the assessment of response to therapy in children with ALL has not been confirmed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tissue Inhibitor of Metalloproteinase-2Matrix Metalloproteinase 2Tumor MicroenvironmentChemokine CXCL10Precursor Cell Lymphoblastic Leukemia-LymphomaMatrix Metalloproteinase 7Chemokine CXCL9HumansChildMaleFemaleChild, PreschoolAdolescentInfant

Stichwörter der Autor:innen

chemokinescytokinesleukemiametalloproteinasespediatric cancertissue inhibitors of metalloproteinasestumor microenvironment

Substanzen

Tissue Inhibitor of Metalloproteinase-2Matrix Metalloproteinase 2Chemokine CXCL10TIMP2 protein, humanMatrix Metalloproteinase 7Chemokine CXCL9CXCL10 protein, humanMMP2 protein, humanMMP7 protein, humanCXCL9 protein, human

Autor:innen und Institutionen

  • Department of Pediatrics, Hematology and Oncology, University Clinical Center of Gdansk, Debinki 7, 80-211 Gdańsk, Poland.
  • Independent Researcher, 81-553 Gdynia, Poland.
  • Division of Clinical Nutrition and Dietetics, Faculty of Health Sciences with the Institute of Maritime and Tropical Medicine, 7 Dębinki, 80-211 Gdańsk, Poland.
  • Department of Paediatrics, Haematology and Oncology, Faculty of Medicine, Medical University of Gdansk, 7 Debinki Street, 80-210 Gdansk, Poland.
  • Department of Pediatric Surgery, Marciniak Hospital, 2 Gen. Augusta Emila Fieldorfa, 54-049 Wroclaw, Poland.
  • Faculty of Health Sciences, Medical University of Gdansk, 3a Maria Sklodowska-Curie Street, 80-210 Gdansk, Poland.

ORCID-Profile: Natalia Miękus-Purwin, Sylwia Małgorzewicz, Małgorzata Rąpała, Joanna Stefanowicz

Förderung

  • Medical University of Gdańsk

Zitieren

APA

Kaczorowska, A., Miękus-Purwin, N., Owczarzak, A., Gabrych, A., Wojciechowska, M., Irga-Jaworska, N., Małgorzewicz, S., Rąpała, M., & Stefanowicz, J. (2025). Selected Elements of the Tumor Microenvironment (MMP-2, MMP-7, TIMP-2, CXCL-9, CXCL-10) in the Serum of Pediatric Patients with Acute Lymphoblastic Leukemia. Cells. https://doi.org/10.3390/cells14040297

Vancouver

Kaczorowska A, Miękus-Purwin N, Owczarzak A, Gabrych A, Wojciechowska M, Irga-Jaworska N, et al. Selected Elements of the Tumor Microenvironment (MMP-2, MMP-7, TIMP-2, CXCL-9, CXCL-10) in the Serum of Pediatric Patients with Acute Lymphoblastic Leukemia. Cells. 2025. doi:10.3390/cells14040297

BibTeX
@article{Kaczorowska2025,
  author = {Kaczorowska, Aleksandra and Miękus-Purwin, Natalia and Owczarzak, Anna and Gabrych, Anna and Wojciechowska, Małgorzata and Irga-Jaworska, Ninela and Małgorzewicz, Sylwia and Rąpała, Małgorzata and Stefanowicz, Joanna},
  title = {Selected Elements of the Tumor Microenvironment (MMP-2, MMP-7, TIMP-2, CXCL-9, CXCL-10) in the Serum of Pediatric Patients with Acute Lymphoblastic Leukemia},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14040297}
}
Kostenlos starten →